Therabron Therapeutics Completes Enrollment of Phase 2 Clinical Trial for Lead Product Candidate CG100 for the Prevention of Chronic Lung Disease in Preterm Infants

ROCKVILLE, MD, May 25, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced the Company has completed enrollment of its […]

By |May 25th, 2016|Uncategorized|

Therabron Therapeutics Appoints Global Pulmonary Experts to the Company’s Scientific Advisory Board

ROCKVILLE, MD, May 19, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, announced today the appointment of four world-renowned experts to […]

By |May 19th, 2016|Recent News|

Therabron Therapeutics Announces Scientific Presentations at the American Thoracic Society (ATS) 2016 International Conference

ROCKVILLE, MD, May 11, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that Aprile Pilon, PhD, Chief Scientific Officer […]

By |May 11th, 2016|Recent News|